Alto Neuroscience, Inc. (ANRO)
17.25
+2.12
(+14.01%)
USD |
NYSE |
Dec 15, 15:21
Alto Neuroscience EPS Diluted (Quarterly): -0.5232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Brainstorm Cell Therapeutics, Inc. | -0.1913 |
| CEL-SCI Corp. | -1.365 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.18M |
| Total Expenses (Quarterly) | 14.18M |
| Enterprise Value | 359.74M |
| Earnings Yield | -13.34% |
| Normalized Earnings Yield | -13.21 |